Program Book - Confex

ACR Poster Session A
121. An Analysis of the Use of Lipid Lowering Agents in
Rheumatoid Arthritis: A Population Based Cohort Study.
Bharath Manu Akkara Veetil, Eric L. Matteson, Sherine E.
Gabriel and Cynthia S. Crowson, Mayo Clinic, Rochester, MN
122. Quality of Care for Rheumatoid Arthritis and Osteoporosis:
Results From the U.S. Medicare Physician Quality
Reporting Program. Jeffrey R. Curtis 1 , Pradeep Sharma 2 ,
Tarun Arora 3 , Aseem Bharat 3 , Michael Morrisey, Kenneth
G. Saag 3 , Itara Barnes 5 and Elizabeth S. Delzell 3 , 1 Univ
of Alabama-Birmingham, Birmingham, AL, 2 University
of Alabama at Birmingham, 3 University of Alabama at
Birmingham, Birmingham, AL, 4 Atlanta, GA
123. DMARD Underuse in the Medicare Current Beneficiary
Survey: Evidence for Socioeconomic Disparities. Daniel H.
Solomon 1 , John Z. Ayanian 2 , Bing Lu 3 , M. Alan Brookhart 4 ,
Sebastian Schneeweiss 5 , Tamara Shaykevich 1 and Jeffrey N.
Katz 1 , 1 Brigham & Womens Hospital, Boston, MA, 2 Brigham
and Women’s Hospital, 3 Brigham and Women’s Hospital,
Boston, MA, 4 University of North Carolina, 5 Harvard
University, Boston, MA
124. Patients Whose Global Estimates Are Higher Than Their
Physician’s Global Estimates Are More Likely to Be Female,
Have Fewer Years of Formal Education, and Higher RAPID3
(Routine Assessment of Patient Index Data) Scores. Isabel
Castrejón 1 , Yusuf Yazici 2 , Jonathan Samuels 1 and Theodore
Pincus 1 , 1 NYU Hospital for Joint Diseases, New York, NY,
2
Division of Rheumatology, New York University School of
Medicine and NYU Hospital for Joint Diseases, New York, NY
125. What Factors Affect Discordance Between Physicians and
Patients in Assessments of Global Health in Rheumatoid
Arthritis Soo-Kyung Cho 1 , Yoon-Kyoung Sung 1 , So-Yeon
Park 1 , Jeeseon Shim 2 , Chan-Bum Choi 3 , Hoon-Suk Cha 4 ,
Jung-Yoon Choe 5 , Won-Tae Chung 6 , Jae Bum Jun 7 , Tae-
Hwan Kim 8 , Tae-Jong Kim 9 , Eun-Mi Koh 4 , Jisoo Lee 10 ,
Shin-Seok Lee 9 , Sung Hoon Park 5 , Wan-sik Uhm 7 , Dae-Hyun
Yoo 8 , Bo Young Yoon 11 , Sang-Cheol Bae 1 and KORONA
investigators 12 , 1 Hanyang University Hospital for Rheumatic
Diseases, Clinical Research Center for Rheumatoid Arthritis
(CRCRA), Seoul, South Korea, 2 Clinical Research Center for
Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 3 Hanyang
University Hospital for Rheumatic Disease, Clinical Research
Center for Rheumatoid Arthritis (CRCRA), Seoul, South
Korea, 4 Samsung Medical Center, Sungkyunkwan University
School of Medicine, Seoul, South Korea, 5 Catholic University
of Daegu School of Medicine, Daegu, South Korea, 6 Dong-A
University, Busan, South Korea, 7 Hanyang University Hospital
for Rheumatic Disease, Seoul, South Korea, 8 Hanyang
University Hospital for Rheumatic Diseases, Seoul, South
Korea, 9 Chonnam National University Medical School and
Hospital, Gwangju, South Korea, 10 Ewha Womans University
Mokdong Hospital, Seoul, South Korea, 11 Inje University Ilsan
Paik Hospital, Goyang, South Korea, 12 Seoul, South Korea
126. Relative Effectiveness of Rituximab and An Alternative
TNF Inhibitor in Patients with Rheumatoid Arthritis
and An Inadequate Response to a Single Previous TNF
Inhibitor: Interim Results From Switch-RA a Global
Comparative-Effectiveness Observational Study. Paul
Emery 1 , Piercarlo Sarzi-Puttini 2 , Robert J. Moots 3 , Alexandros
A. Andrianakos 4 , Thomas P. Sheeran 5 , Denis Choquette 6 , Axel
Finckh 7 , Marie-Laetitia Desjuzeur 8 , Eric Gemmen 9 , Chiedzo
Mpofu 8 and Jacques-Eric Gottenberg 10 , 1 Leeds Institute of
Molecular Medicine, University of Leeds and NIHR Leeds
Musculoskeletal Biomedical Research Unit, Leeds, UK,
Leeds, United Kingdom, 2 L Sacco University Hospital, Milano,
Italy, 3 University of Liverpool, Liverpool, United Kingdom,
4
Hellenic Foundation for Rheumatological Research, Athens,
Greece, 5 Cannock Chase Hospital, Cannock, United Kingdom,
6
University of Montreal, Notre-dame Hospital, Montreal,
QC, 7 University Hospital of Geneva, Geneva, Switzerland,
8
F. Hoffman-La Roche Ltd, Basel, Switzerland, 9 Quintiles Inc,
Rockville, MD, 10 CHU Strasbourg, Strasbourg, France
127. Direct and Indirect Effects of Disease Activity on Functional
disability in Rheumatoid Arthritis Patients Over Time and
the Effect of Increasing Intensive Treatments: Results
From Early Utrecht Rheumatoid Arthritis Cohort Study
Group. Sandhya C. Nair, P.M.J. Welsing, F.P.J.G. Lafeber and
J.W.J. Bijlsma, University Medical Center Utrecht, Utrecht,
Netherlands
128. Rheumatoid Arthritis Continues to Improve in the New
Millennium Whilst Use of Medication Change. Findings
From a Representative Rheumatoid Arthritis Register
Over 15 Years. Cathrine Austad, Tore K. Kvien and Till Uhlig,
Diakonhjemmet Hospital, Oslo, Norway
129. Perceived Benefits of Intravenous Biologic Therapy Among
Patients with Rheumatoid Arthritis. Susan Bolge, Julie
Vanderpoel, Helen Eldridge, Samir Mody and Mike Ingham,
Janssen Services, LLC, Horsham, PA
130. The Effect of Arthritis Self Management Program on
Outcome in African-Americans with Rheumatoid Arthritis
Served by a Public Hospital. Athan N. Tiliakos 1 , Yi Pan 2 , Kirk
Easley 3 , Steven D. Culler 2 and Doyt L. Conn 1 , 1 Emory Univ
School of Medicine, Atlanta, GA, 2 Emory University-Rollins
School of Public Health, 3 Emory University-Rollins School of
Public Health, Atlanta, GA
131. Effort-Reward Imbalance in Patients with Rheumatoid
Arthritis Jutta G. Richter, Thomas Muth, Birthe Koerbl,
Nicole Hoffmann, Tobias Koch, Johannes Siegrist and
Matthias Schneider, Heinrich-Heine-University, Duesseldorf,
Germany
132. Who Are the Patients with Early Arthritis Who Score
States “worse Than death” on the EQ-5D Results From
the ESPOIR Cohort. Cécile Gaujoux-Viala 1 , Bruno Fautrel 2 ,
Francis Guillemin 3 , René-Marc Flipo 4 , Patrice Fardellone 5 ,
Pierre Bourgeois 2 and Anne-Christine Rat 3 , 11 Nancy-
University, Paul Verlaine Metz University, Paris Descartes
University, EA 4360 Apemac, Nancy, France, 2 Paris 6 – Pierre
140
2011 Program Book